Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Endothelial progenitor cell

Koyanagi M, Brandes RP, Haendeler J, Zeiher AM, Dimmeler S (2005) Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes A novel mechanism for cell fate changes Circ. Res. 96 1039-1041. [Pg.371]

Endothelial progenitor cells can be isolated from the mononuclear fraction of the bone marrow or peripheral blood, as well as from fetal liver or umbilical cord blood [12, 23, 66, 67], Heterologous,... [Pg.99]

Endothelial progenitor cell numbers appear to decrease in the presence of risk factors for CAD and to correlate negatively with Framingham cardiovascular risk factors [31]. Therefore, stem cell therapy with EPCs may prove very useful in the clinical setting of cardiovascular disease. The kinetic and biological properties of EPCs may be especially appropriate for autologous transplantation. EPCs may also be safe to use in elderly and diabetic patients, populations in which they do not tend to migrate as much or induce neovascularization [68]. [Pg.101]

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 103 2776-2779. [Pg.122]

Rumpold H, Wolf D, Koeck R, Gunsilius E. Endothelial progenitor cells a source for therapeutic vasculogenesis J Cell Mol Med 2004 8 509-518. [Pg.122]

Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999 85 221-228. [Pg.122]

Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EM BO J 1999 18 3964-3972. [Pg.122]

Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998 125 1457-1468. [Pg.122]

Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002 105 732-738. [Pg.122]

Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, AtalaA, Soker S, BischoffJ, Mayer JE Jr. Eunctional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001 7 1035-1040. [Pg.122]

Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 89 El-7. [Pg.122]

Iwami Y, Masuda H, Asahara T. Endothelial progenitor cells past, state of the art, and future. J Cell Mol Med 2004 8 488 97. [Pg.122]

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Mefi 2005 353 999-1007. [Pg.123]

Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 111 2981-2987. [Pg.123]

Hristov M, Erl W, Weber PC. Endothelial progenitor cells mobilization, differentiation, and homing. Arter-ioscler Thromb Vase Biol 2003 23 1185-1189. [Pg.124]

Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh lY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005 112 1618-1627. [Pg.124]

Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003 107 2134-2139. [Pg.125]

Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003 107 461-468. [Pg.126]

Strehlow K, Werner N, Berweiler J, Link A, Dimagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Bohm M, Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003 107 3059-3065. [Pg.128]

Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vase Biol 2004 24 684-690. [Pg.128]

George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, Keren G. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vase Biol 2003 23 e57-60. [Pg.128]

Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 108 391-397. [Pg.128]

Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D. Erythropoietin regulates endothelial progenitor cells. Stood 2004 103 921-926. [Pg.128]

Other effects Reduced platelet reactivity Increased t-PA and decreased plasminogen activator inhibitor-1 Increased circulating endothelial progenitor cells... [Pg.163]

Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 103 2885-2890. [Pg.169]

Abbreviations Ad-beta gal, beta-galactosidase AS-ODN, antisense oligonucleotides EC, endothelial cell EEC, endothelial progenitor cell NA, not available ... [Pg.260]


See other pages where Endothelial progenitor cell is mentioned: [Pg.367]    [Pg.228]    [Pg.8]    [Pg.369]    [Pg.377]    [Pg.95]    [Pg.95]    [Pg.96]    [Pg.99]    [Pg.102]    [Pg.123]    [Pg.123]    [Pg.128]    [Pg.99]    [Pg.101]    [Pg.1902]    [Pg.242]    [Pg.166]    [Pg.169]    [Pg.258]   
See also in sourсe #XX -- [ Pg.97 , Pg.99 , Pg.100 ]

See also in sourсe #XX -- [ Pg.142 ]

See also in sourсe #XX -- [ Pg.243 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.467 ]

See also in sourсe #XX -- [ Pg.85 ]




SEARCH



Circulating endothelial progenitor cells

Endothelial

Endothelial cells

Endothelialization

© 2024 chempedia.info